Acturadar.comFrance in real time
Progestins and meningioma risk: patient testimonies

Ongoing3 events · of the 9 Nov au 13 Nov · latest fact at 17h30

View entire story

Fact 3 of 3 in the story · Friday 13 November, 17h30

Testimony of a patient treated with Androcur and suffering from meningiomas

Claire says she took Androcur for 18 years and developed meningiomas, while hundreds of thousands of women have been exposed to this anti-androgen in France.

In brief

Health event (severity: low) nationwide, first detected on 13 November 2026 at 17:30. Reported by 1 source (1 article), last updated on 13 November 2026 at 17:30. Part of the story “Progestins and meningioma risk: patient testimonies”.

·
Category
Health
Severity
Low
Place

National

Detected
13 Nov, 17h30
Updated
13 Nov, 17h30
Reference
no.19393
01

What changed in the story at that point

02

Who is covering it, and from what angle

Method
1Uncategorised

1 article · 1 source · no rated outlet covers this topic yet (public service, agencies, official accounts…)

Angle comparison

A comparison is written as soon as the event is covered by at least two sides (left, centre, right).

03

Lire les sources · 1 article, 1 source

Publication order
  1. 17h30
    France 3 RégionsReport13 Nov
    TÉMOIGNAGE. Méningiomes, PMA, bébé miracle… Comment Claire s'est reconstruite après des violences médicales

    Entre 2006 et 2014, au moins 400 000 femmes en France, atteintes de troubles hormonaux, ont été traitées avec Androcur. Mais cet anti-androgène est responsable de cas de méningiomes (tumeurs des méninges) chez les patientes exposées. Parmi elles, Claire, qui a pris le traitement pendant 18 ans. Témoignage.

04

Further reading